Ms. Fish was most recently the Chief Human Resources Officer for Marlin Equity Partners, a private equity firm.
SAN FRANCISCO, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Invuity, (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the strengthening of its executive management team with the appointment of Marcia Fish as Chief Human Resources Officer, effective October 2, 2017. She will report to Invuity CEO Phillip Sawyer and will have direct responsibility for the company’s people strategy including talent acquisition, talent development and building organizational capability to further support Invuity’s growth.
Mr. Sawyer said, “We are thrilled to have Marcia join our team and leverage her expertise from her work with both smaller and larger companies as we look to grow our talent base and refine our processes to continue to scale. This is a transformational time for Invuity, and we look forward to Marcia’s contribution.”
Ms. Fish was most recently the Chief Human Resources Officer for Marlin Equity Partners, a private equity firm, where she worked with their portfolio of companies, spanning sectors including healthcare and technology. Prior to that, Ms. Fish spent 21 years at General Electric (GE) in roles of increasing responsibility, including serving as Human Resources lead for several US and ex-US businesses. Ms. Fish has a Bachelor’s degree from Cornell University’s Department of Industrial and Labor Relations and an MBA from Duke University’s Fuqua School of Business.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company’s patented Intelligent Photonics™ technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company utilizes comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT:
Company Contact:
Jim Mackaness
Chief Financial Officer
Invuity, Inc.
415-655-2129
Investors:
Mark Klausner
Westwicke Partners
443-213-0501
irdept@invuity.com
